239 related articles for article (PubMed ID: 29926531)
41. LDL suppresses angiogenesis through disruption of the HIF pathway via NF-κB inhibition which is reversed by the proteasome inhibitor BSc2118.
Yao G; Zhang Q; Doeppner TR; Niu F; Li Q; Yang Y; Kuckelkorn U; Hagemann N; Li W; Hermann DM; Dai Y; Zhou W; Jin F
Oncotarget; 2015 Oct; 6(30):30251-62. PubMed ID: 26388611
[TBL] [Abstract][Full Text] [Related]
42. Comparative Analysis of miRNA Expression Profiles of Multiple Myeloma with 1q21 Gains and Normal FISH.
Cui Y; Liu Y; Wang D; Liu Y; Liu L; Fang B
Acta Haematol; 2018; 139(2):96-100. PubMed ID: 29402764
[TBL] [Abstract][Full Text] [Related]
43. Regulation of the hypoxia-inducible factor-1 alpha. ARNT is not necessary for hypoxic induction of HIF-1 alpha in the nucleus.
Gassmann M; Chilov D; Wenger RH
Adv Exp Med Biol; 2000; 475():87-99. PubMed ID: 10849651
[TBL] [Abstract][Full Text] [Related]
44. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
[TBL] [Abstract][Full Text] [Related]
45. HIF-2α/ARNT complex regulates hair development via induction of p21(Waf1/Cip1) and p27(Kip1).
Imamura Y; Tomita S; Imanishi M; Kihira Y; Ikeda Y; Ishizawa K; Tsuchiya K; Tamaki T
FASEB J; 2014 Jun; 28(6):2517-24. PubMed ID: 24599965
[TBL] [Abstract][Full Text] [Related]
46. Hypoxia regulates avian cardiac Arnt and HIF-1alpha mRNA expression.
Catron T; Mendiola MA; Smith SM; Born J; Walker MK
Biochem Biophys Res Commun; 2001 Mar; 282(2):602-7. PubMed ID: 11401503
[TBL] [Abstract][Full Text] [Related]
47. Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.
Nemec P; Zemanova Z; Greslikova H; Michalova K; Filkova H; Tajtlova J; Kralova D; Kupska R; Smetana J; Krejci M; Pour L; Zahradova L; Sandecka V; Adam Z; Buchler T; Spicka I; Gregora E; Kuglik P; Hajek R
Biol Blood Marrow Transplant; 2010 Apr; 16(4):548-54. PubMed ID: 20005965
[TBL] [Abstract][Full Text] [Related]
48. [Prognostic factors in newly diagnosed multiple myeloma patients with 1q21 amplification/gain treated with bortezomib-based regimens followed by autologous hematopoietic stem cell transplantation].
Huang WY; Zou DH; Liu W; An G; Xu Y; Sui WW; Deng SH; Li CW; Liu H; Li J; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):496-500. PubMed ID: 30032568
[No Abstract] [Full Text] [Related]
49. Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes.
Weir L; Robertson D; Leigh IM; Vass JK; Panteleyev AA
Biochim Biophys Acta; 2011 Jan; 1813(1):60-72. PubMed ID: 21129412
[TBL] [Abstract][Full Text] [Related]
50. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
[TBL] [Abstract][Full Text] [Related]
51. Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21.
Nahi H; Våtsveen TK; Lund J; Heeg BM; Preiss B; Alici E; Møller MB; Wader KF; Møller HE; Grøseth LA; Østergaard B; Dai HY; Holmberg E; Gahrton G; Waage A; Abildgaard N
Eur J Haematol; 2016 Jan; 96(1):46-54. PubMed ID: 25779478
[TBL] [Abstract][Full Text] [Related]
52. Heterogeneous chromosome 12p deletion is an independent adverse prognostic factor and resistant to bortezomib-based therapy in multiple myeloma.
Li F; Xu Y; Deng P; Yang Y; Sui W; Jin F; Hao M; Li Z; Zang M; Zhou D; Gu Z; Ru K; Wang J; Cheng T; Qiu L
Oncotarget; 2015 Apr; 6(11):9434-44. PubMed ID: 25831238
[TBL] [Abstract][Full Text] [Related]
53. Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens.
Liu X; Jia S; Chu Y; Tian B; Gao Y; Zhang C; Zheng Y; Jia W; Liu X; Yuan R; Zhang N; Feng J; Dong H; Xin X; Chang Z; Cao Z; Tang H; Gao G
Front Oncol; 2022; 12():938550. PubMed ID: 36185185
[TBL] [Abstract][Full Text] [Related]
54. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT.
Zelzer E; Levy Y; Kahana C; Shilo BZ; Rubinstein M; Cohen B
EMBO J; 1998 Sep; 17(17):5085-94. PubMed ID: 9724644
[TBL] [Abstract][Full Text] [Related]
55. The role of ARNT2 in tumor angiogenesis and the neural response to hypoxia.
Maltepe E; Keith B; Arsham AM; Brorson JR; Simon MC
Biochem Biophys Res Commun; 2000 Jun; 273(1):231-8. PubMed ID: 10873592
[TBL] [Abstract][Full Text] [Related]
56. Expression of aryl hydrocarbon receptor nuclear translocator enhances cisplatin resistance by upregulating MDR1 expression in cancer cells.
Chan YY; Kalpana S; Chang WC; Chang WC; Chen BK
Mol Pharmacol; 2013 Oct; 84(4):591-602. PubMed ID: 23907215
[TBL] [Abstract][Full Text] [Related]
57. Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma.
Ikeda S; Abe F; Matsuda Y; Kitadate A; Takahashi N; Tagawa H
Cancer Sci; 2020 Nov; 111(11):4088-4101. PubMed ID: 32790954
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma.
Zheng Z; Fan S; Zheng J; Huang W; Gasparetto C; Chao NJ; Hu J; Kang Y
J Hematol Oncol; 2018 Feb; 11(1):29. PubMed ID: 29482577
[TBL] [Abstract][Full Text] [Related]
59. Aromatic hydrocarbon receptor inhibits lysophosphatidic acid-induced vascular endothelial growth factor-A expression in PC-3 prostate cancer cells.
Wu PY; Lin YC; Lan SY; Huang YL; Lee H
Biochem Biophys Res Commun; 2013 Aug; 437(3):440-5. PubMed ID: 23831623
[TBL] [Abstract][Full Text] [Related]
60. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
